MarketWatch The trial evaluated use of oral pomalidomide plus low-dose dexamethasone (n=302) compared with high-dose dexamethasone (n=153) in patients with relapsed and refractory multiple myeloma; according to the protocol, all patients were to have been ...
The Herald | HeraldOnline.com Three global Phase 3 trials are on-going; TOURMALINE-MM1, investigating MLN9708 in combination with lenalidomide and dexamethasone in relapsed and/or refractory MM, TOURMALINE-MM2, investigating MLN9708 in combination with lenalidomide ... and more »
Seeking Alpha In one of the trials it is tested in combination with Velcade and dexamethasone and in the other in combination with Revlimid and dexamethasone in pati...
StreetInsider.com (subscription) In the study, presented by Katja Weisel, M.D., Department of Medicine, University Hospital Tübingen, Tübingen, Germany, 455 patients wer...
Business Wire (press release) BUSINESS WIRE)--Ocular Therapeutix, Inc. announced today it has completed enrollment for its sustained release dexamethasone (OTX-DP) in a Phase II study under an Investigational New Drug (IND) submission to the Food and Drug Administration (FDA). and more »
